1. Home
  2. Publications & Reports
  3. Policy Directives & Guidelines
  4. Opioid Treatment Program: Clinical Guidelines for methadone and buprenorphine treatment
Print this page Reduce font size Increase font size

Opioid Treatment Program: Clinical Guidelines for methadone and buprenorphine treatment

Doc type: Guideline

Doc No.: GL2006_019

Functional Group - Sub Group:
Clinical/ Patient Services - Medical Treatment
Clinical/ Patient Services - Pharmaceutical
Population Health - Pharmaceutical

Summary
To provide up to date policy and clinical practice guidelines in New South Wales for opioid treatment programs to treat heroin and other opioid dependence.

NOTE: Appendix V Guidelines and Information Sheets regarding Suboxone Sublingual Film was included in this Guideline on 31 August 2011 as advised by Information Bulletin IB2011_037.

Date of Publication: 22 November 2006

Replaces:

  • Buprenorphine in Treatment of Opioid Dependence [PD2005_216]
Author Branch: Centre for Population Health

This document applies to: Area Health Services/Chief Executive Governed Statutory Health Corporation, Board Governed Statutory Health Corporations, Affiliated Health Organisations, Affiliated Health Organisations - Declared

Audience: Prescribers of opioid treatment, staff of drug treatment services

Distributed to: Public Health System, NSW Ambulance Service , Ministry of Health

Review Date: 22 November 2011

Policy Manual: Not applicable

File No: 05/4709

Status: Active

File link: Opioid Treatment Program: Clinical Guidelines for methadone and buprenorphine treatment
File size: 4081Kb

Opioid Treatment Program: Clinical Guidelines for methadone and buprenorphine treatment

Print this page Reduce font size Increase font size